Schedule 13G ownership disclosure

SINGULAR GENOMICS SYSTEMS IN

Common Stock par value $0.0001 per share · CUSIP: 82933R308

Event date: 2025-02-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • ARCH Venture Fund IX, L.P.

    Shares: 0.00 · Class: 0%

  • ARCH Venture Partners IX, L.P.

    Shares: 0.00 · Class: 0%

  • ARCH Venture Partners IX, LLC

    Shares: 0.00 · Class: 0%

  • Keith Crandell

    Shares: 0.00 · Class: 0%

  • Clinton Bybee

    Shares: 0.00 · Class: 0%

  • Robert Nelsen

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-25-000406
Form type
SCHEDULE 13G/A
Filer
ARCH Venture Fund IX, L.P.
CIK
CIK 1666306
Filed
May 15, 2025
Reporting period
Feb 21, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub